US 11,850,427 B2
Methods and systems of improving and monitoring addiction using cue reactivity
Ali Rezai, Morgantown, WV (US); Victor Finomore, Morgantown, WV (US); and James Mahoney, Morgantown, WV (US)
Assigned to WEST VIRGINIA UNIVERSITY BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIVERSITY, Morgantown, WV (US)
Filed by West Virginia University Board of Governors on behalf of West Virginia University, Morgantown, WV (US)
Filed on Dec. 2, 2020, as Appl. No. 17/110,174.
Claims priority of provisional application 62/942,340, filed on Dec. 2, 2019.
Prior Publication US 2021/0162217 A1, Jun. 3, 2021
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01); A61N 2/00 (2006.01); G16H 50/30 (2018.01); G16H 20/40 (2018.01); G16H 20/70 (2018.01); A61N 7/00 (2006.01)
CPC A61N 1/36089 (2013.01) [A61N 1/0534 (2013.01); A61N 2/002 (2013.01); A61N 2/006 (2013.01); A61N 7/00 (2013.01); G16H 20/40 (2018.01); G16H 20/70 (2018.01); G16H 50/30 (2018.01); A61N 2007/0026 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A method of improving addiction to an addictive behavior or addictive chemical substance in a patient in need thereof comprising:
obtaining a measurement of the patient's baseline craving level for the addictive behavior or addictive chemical substance;
providing the patient exposure to a cue associated with the addictive behavior or addictive chemical substance;
obtaining a subsequent measurement of the patient's resultant craving level for the addictive behavior or addictive chemical substance during or after exposure to the cue; and
delivering a neuromodulation signal comprising a focused ultrasound signal, a transcranial magnetic stimulation signal, and/or a deep brain stimulation signal to the patient based on a comparison of the baseline craving level and the resultant craving level to improve the patient's addiction.